Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SNORA17B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
ARID3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
VARS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928069 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF467 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASB6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NARFL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TGFB1I1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMDT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FASTK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OBSL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHKB-CPT1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DAGLB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBC1D13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MROH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C19orf60 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MZF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on